ABBOTT DIABETES CARE SALES CORP

Abbott Diabetes Care Sales Corp specializes in the manufacturing of in-vitro diagnostic substances, with a focus on clinical testing materials used in glucose monitoring and metabolic health assessment. Their technical expertise lies in the development and production of precision-engineered reagents, biosensors, and consumables that support point-of-care and laboratory-based diagnostic systems. The company’s capabilities center on regulatory-compliant manufacturing processes for medical-grade diagnostic substances, ensuring consistency, stability, and biocompatibility required for FDA-regulated products. While their award history is limited, the most recent modification under HHS suggests active participation in administrative and supply chain support for federally procured diagnostic materials, indicating alignment with public health infrastructure needs. The contractor has demonstrated engagement with the Department of Health and Human Services, primarily in support of diagnostic product procurement and administrative modifications to existing supply agreements. This relationship reflects a role in sustaining the federal healthcare system’s access to critical diagnostic tools, particularly in diabetes management and chronic disease monitoring. Their primary industry focus is on in-vitro diagnostic substance manufacturing, a niche within the broader medical device and laboratory diagnostics sector. This involves the formulation, purification, and packaging of biochemical reagents used in blood glucose strips, test cartridges, and other diagnostic platforms. The company positions itself as a specialized supplier within the public health diagnostics supply chain, serving agencies reliant on reliable, high-volume diagnostic consumables. Abbott Diabetes Care Sales Corp operates as a limited liability entity based in Alameda, California. The company holds no active government certifications, and its market presence is confined to its physical location and direct contractual engagements with federal health agencies. Despite limited public award data, its core function places it within a critical segment of the U.S. healthcare diagnostics infrastructure.